The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The value of 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) in the detection of the primary lesion and for staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS).
 
Emilie Le Rhun
Research Funding - Amgen (Inst); Mundipharma (Inst)
 
Michael Weller
Honoraria - ImmunoCellular Therapeutics; Lilly; Merck Serono; MSD; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celldex; Lilly; Magforce; Merck Serono; Pfizer; Roche; Teva
Research Funding - Acceleron Pharma (Inst); Actelion (Inst); Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst)
 
Anna Sophie Berghoff
Honoraria - Amgen; Bristol-Myers Squibb; Roche
 
Elisabeth Jane Rushing
No Relationships to Disclose
 
Lisa Fuereder
No Relationships to Disclose
 
Gregory Petyt
No Relationships to Disclose
 
Henning Leske
No Relationships to Disclose
 
Nicolaus Andrastschke
No Relationships to Disclose
 
Luca Regli
No Relationships to Disclose
 
Marian Christoph Neidert
No Relationships to Disclose
 
Roger Stupp
Employment - Celgene (I)
Stock and Other Ownership Interests - Celgene (I)
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Novocure
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Takeda
 
Thomas Frauenfelder
No Relationships to Disclose
 
Patrick Roth
No Relationships to Disclose
 
Nicolas Reyns
No Relationships to Disclose
 
Philipp Antonio Kaufmann
No Relationships to Disclose
 
Matthias Preusser
Honoraria - GlaxoSmithKline; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche
 
Fabian Wolpert
No Relationships to Disclose